ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,055,000 | +6416.2% | 260,196 | +1697.6% | 0.09% | +8700.0% |
| Q4 2017 | $185,000 | -92.3% | 14,475 | -95.0% | 0.00% | -93.8% |
| Q2 2017 | $2,406,000 | +11.2% | 287,449 | +18.8% | 0.02% | -5.9% |
| Q1 2017 | $2,164,000 | +525.4% | 242,012 | +372.5% | 0.02% | +750.0% |
| Q3 2016 | $346,000 | +686.4% | 51,220 | +389.0% | 0.00% | – |
| Q4 2015 | $44,000 | -82.5% | 10,475 | -79.0% | 0.00% | -100.0% |
| Q4 2013 | $251,000 | -45.0% | 50,000 | -50.2% | 0.00% | -60.0% |
| Q2 2013 | $456,000 | – | 100,387 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |